Alessandro Doria

New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.

Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, Grams ME, Greene T, Grubb A, Gudnason V, Gutiérrez OM, Kalil R, Karger AB, Mauer M, Navis G, Nelson RG, Poggio ED, Rodby R, Rossing P, Rule AD, Selvin E, Seegmiller JC, Shlipak MG, Torres VE, Yang W, Ballew SH, Couture SJ, Powe NR, Levey AS.

N Engl J Med. 2021 Sep 23. PMID: 34554658

Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes.

Satake E, Saulnier PJ, Kobayashi H, Gupta MK, Looker HC, Wilson JM, Md Dom ZI, Ihara K, O'Neil K, Krolewski B, Pipino C, Pavkov ME, Nair V, Bitzer M, Niewczas MA, Kretzler M, Mauer M, Doria A, Najafian B, Kulkarni RN, Duffin KL, Pezzolesi MG, Kahn CR, Nelson RG, Krolewski AS.

J Am Soc Nephrol. 2021 Sep. 32(9):2331-2351. PMID: 34140396

Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia Treatment.

Mariam A, Miller-Atkins G, Pantalone KM, Zimmerman RS, Barnard J, Kattan MW, Shah H, McLeod HL, Doria A, Wagner MJ, Buse JB, Motsinger-Reif AA, Rotroff DM.

Diabetes Care. 2021 Apr 16. PMID: 33863751

Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells.

Charoensuk C, Thamtarana PJ, Chanprasert C, Tangjittipokin W, Shirakawa J, Togashi Y, Orime K, Songprakhon P, Chaichana C, Abubakar Z, Ouying P, Sujjitjoon J, Doria A, Plengvidhya N, Yenchitsomanus PT.

Mol Cell Endocrinol. 2021 02 15. 522:111126. PMID: 33321115

Disentangling the heterogeneity of adulthood-onset non-autoimmune diabetes: a little closer but lot more to do.

Trischitta V, Prudente S, Doria A.

Curr Opin Pharmacol. 2020 12. 55:157-164. PMID: 33271410

Intensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial.

Tang Y, Shah H, Bueno Junior CR, Sun X, Mitri J, Sambataro M, Sambado L, Gerstein HC, Fonseca V, Doria A, Pop-Busui R.

Diabetes Care. 2021 01. 44(1):164-173. PMID: 33144354

Allopurinol and Chronic Kidney Disease. Reply.

Doria A, Galecki AT, Mauer M.

N Engl J Med. 2020 10 22. 383(17):1690-1691. PMID: 33085876

Association of the 1q25 Diabetes-Specific Coronary Heart Disease Locus With Alterations of the ?-Glutamyl Cycle and Increased Methylglyoxal Levels in Endothelial Cells.

Pipino C, Shah H, Prudente S, Di Pietro N, Zeng L, Park K, Trischitta V, Pennathur S, Pandolfi A, Doria A.

Diabetes. 2020 10. 69(10):2206-2216. PMID: 32651240

Uric acid and risk of diabetic kidney disease.

Mauer M, Doria A.

J Nephrol. 2020 Oct. 33(5):995-999. PMID: 32651849

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.

Doria A, Galecki AT, Spino C, Pop-Busui R, Cherney DZ, Lingvay I, Parsa A, Rossing P, Sigal RJ, Afkarian M, Aronson R, Caramori ML, Crandall JP, de Boer IH, Elliott TG, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Maahs DM, McGill JB, Molitch ME, Perkins BA, Polsky S, Pragnell M, Robiner WN, Rosas SE, Senior P, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M.

N Engl J Med. 2020 06 25. 382(26):2493-2503. PMID: 32579810